Author Correction: Compound Opening Arrow Mixture exerts anti-tumor effects in a mouse model of breast cancer

Correction to: Scientific Reports https://doi.org/10.1038/s41598-020-64561-9, published online 18 May 2020

The original version of this Article contained an error in Figure 1a, where 14d image did not display correctly.

The original Figure 1 and accompanying legend appear below.

Figure 1

In vivo imaging results of transplanted breast cancer cells 4TI-Luc in mice. (a–b) Female BALB/c-nu mice were inoculated with luciferase-labeled mouse breast cancer cells 4T1-luc. Mice were mock-treated with saline, were treated with low-molecular-weight heparin, or various doses of Compound Opening Arrow Mixture (COAM) after successful modeling. The growth of transplanted tumor cells was observed using a small animal in vivo imaging system on the 1st day after successful modeling and on the 7th and 14th day after drug administration. (a) Representative in vivo images of mice on the 7th day after drug administration. (b) Summarized data on total photon number of transplanted tumor cells (p/s/mm2) in the indicated groups at specified time points. Normal control group, mice without inoculation of tumors and treatments; Model group, mice with inoculation of tumors and treatments with saline; LMWH group, mice with inoculation of tumors and treatments with 1500 U/Kg low-molecular-weight heparin once a day by gavage; COAM high-dose group, mice with inoculation of tumors and treatments with high-dose of COAM (6 g/ml) once daily by gavage; COAM medium-dose group, mice with inoculation of tumors and treatments with medium-dose of COAM (3 g/ml) once daily by gavage; COAM low-dose group, mice with inoculation of tumors and treatments with low-dose of COAM (1.5 g/ml) once daily by gavage. n = 5 for each group.

The original Article has been corrected.